{
    "title": "108_hr2157",
    "content": "The Act is titled the \"Uterine Fibroid Research and Education Act of 2003\". Congress finds that uterine fibroids are a common health issue affecting women of all ages and races, with symptomatic fibroids causing various problems including heavy bleeding and infertility. African American women are more likely to develop uterine fibroids. Uterine fibroids are a leading cause of hysterectomies. The estimated annual charges for inpatient care for uterine fibroids exceeded $2 billion in 1997, with a lack of high-quality evidence supporting the effectiveness of most interventions for symptomatic fibroids. Research with respect to uterine fibroids. The Director of the National Institutes of Health will expand and coordinate research programs on uterine fibroids through various institutes and offices, including the National Institute of Child Health and Human Development. The Office of Research on Women's Health will oversee the coordination of these activities. Women's Health will coordinate activities among the National Institutes of Health entities. $10,000,000 is authorized for each fiscal year from 2004 to 2008 for this purpose. SEC. 4. INFORMATION AND EDUCATION REGARDING UTERINE FIBROIDS. The Secretary of Health and Human Services will develop and share information on uterine fibroids, including their prevalence, higher risk for minority women, and available treatment options. The Secretary, through the Health Resources and Services Administration, will provide information on uterine fibroids to healthcare providers, focusing on the elevated risk for minority women and treatment options. Authorization of appropriations is provided for fiscal years 2004 through 2008. The text discusses the range of treatment options for symptomatic uterine fibroids and authorizes appropriations for fiscal years 2004 through 2008. The term \"minority\" is defined as women who are members of racial or ethnic minority groups."
}